Flynn Zito Capital Management’s CVS Health CVS Stock Holding History

Flynn Zito Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,333	Closed	-$266K	–	118
2024 Q1	$266K	Buy	3,333 +5	+0.2%	+$382	0.14%	83
2023 Q4	$263K	Buy	3,328 +6	+0.2%	+$427	0.18%	68
2023 Q3	$232K	Buy	3,322 +5	+0.2%	+$354	0.16%	61
2023 Q2	$229K	Buy	3,317 +105	+3%	+$7.47K	0.15%	63
2023 Q1	$239K	Buy	3,212 +4	+0.1%	+$335	0.17%	59
2022 Q4	$299K	Buy	3,208 +3	+0.1%	+$289	0.25%	55
2022 Q3	$306K	Buy	+3,205	New	+$317K	0.3%	44
2022 Q2	–	Sell	-2,980	Closed	-$302K	–	76
2022 Q1	$302K	Buy	2,980 +3	+0.1%	+$315	0.26%	49
2021 Q4	$308K	Buy	+2,977	New	+$275K	0.26%	49

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Flynn Zito Capital Management's CVS Position: Q2 2024 in Review

Flynn Zito Capital Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,333 shares — an estimated $266K sold.

Flynn Zito Capital Management first reported a position in CVS in Q4 2021 and held it in 9 quarters. The position peaked at $308K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Flynn Zito Capital Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Flynn Zito Capital Management sold 3,333 CVS Health shares in Q2 2024, an estimated $266K.
Flynn Zito Capital Management first reported a position in CVS Health in Q4 2021 and held it in 9 quarters.
Flynn Zito Capital Management's CVS Health position peaked at $308K in Q4 2021.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Flynn Zito Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.